Cargando…
N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investiga...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731865/ https://www.ncbi.nlm.nih.gov/pubmed/31492783 http://dx.doi.org/10.1136/bmjopen-2019-029885 |
_version_ | 1783449747334365184 |
---|---|
author | Luo, Changjun Zhou, Jianwei Xiong, Si Kang, Zhongqiang Zhang, Jing Sun, Yifan Qin, Biyun Fang, Kuaifa |
author_facet | Luo, Changjun Zhou, Jianwei Xiong, Si Kang, Zhongqiang Zhang, Jing Sun, Yifan Qin, Biyun Fang, Kuaifa |
author_sort | Luo, Changjun |
collection | PubMed |
description | OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investigate the relationship between NT-pro-BNP levels and in-hospital and long-term adverse prognosis in patients with TBAD. DESIGN: A retrospective multicentre study. SETTING: Liutie Central Hospital, Nanfang Hospital and Huiyang Hospital in China. PARTICIPANTS: A total of 657 consecutive patients with TBAD were enrolled in the study. NT-pro-BNP was measured at admission and included patients were divided into three groups according to the tertiles of NT-pro-BNP (pg/mL): <95 (n=220), 95–312 (n=218) and >312 (n=219). PRIMARY AND SECONDARY OUTCOME MEASURES: Long-term mortality and in-hospital major adverse clinical events. RESULTS: Overall, in-hospital death occurred in 27 patients (4.1%), which was significantly higher in upper tertiles of NT-pro-BNP (0.5% vs 4.1% vs 7.8%, p<0.001). The incident of in-hospital major adverse clinical events increased along with higher NT-pro-BNP (1.4% vs 11.5% vs 15.5%, p<0.001). NT-pro-BNP >210 pg/mL had 81.5% sensitivity and 58.6% specificity for predicting in-hospital death (area under the curve= 0.774, 95% CI 0.692 to 0.855; p<0.001). After a median of 3.1 years of follow-up, 97 (14.8%) patients died. The Kaplan-Meier analysis indicated that the long-term cumulative mortality was higher in patients with NT-pro-BNP >210 pg/mL compared with patients with NT-pro-BNP ≤210 pg/mL (log-rank=26.92, p<0.001). In multivariable Cox survival modelling, NT-pro-BNP >210 pg/mL was independently associated with long-term death (adjusted HR 2.47, 95% CI 1.45 to 4.22, p=0.001). CONCLUSIONS: NT-pro-BNP resulted as an independent predictor of adverse prognosis in patients with TBAD, thus could be used as a potential risk-stratification tool. |
format | Online Article Text |
id | pubmed-6731865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67318652019-09-20 N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study Luo, Changjun Zhou, Jianwei Xiong, Si Kang, Zhongqiang Zhang, Jing Sun, Yifan Qin, Biyun Fang, Kuaifa BMJ Open Cardiovascular Medicine OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investigate the relationship between NT-pro-BNP levels and in-hospital and long-term adverse prognosis in patients with TBAD. DESIGN: A retrospective multicentre study. SETTING: Liutie Central Hospital, Nanfang Hospital and Huiyang Hospital in China. PARTICIPANTS: A total of 657 consecutive patients with TBAD were enrolled in the study. NT-pro-BNP was measured at admission and included patients were divided into three groups according to the tertiles of NT-pro-BNP (pg/mL): <95 (n=220), 95–312 (n=218) and >312 (n=219). PRIMARY AND SECONDARY OUTCOME MEASURES: Long-term mortality and in-hospital major adverse clinical events. RESULTS: Overall, in-hospital death occurred in 27 patients (4.1%), which was significantly higher in upper tertiles of NT-pro-BNP (0.5% vs 4.1% vs 7.8%, p<0.001). The incident of in-hospital major adverse clinical events increased along with higher NT-pro-BNP (1.4% vs 11.5% vs 15.5%, p<0.001). NT-pro-BNP >210 pg/mL had 81.5% sensitivity and 58.6% specificity for predicting in-hospital death (area under the curve= 0.774, 95% CI 0.692 to 0.855; p<0.001). After a median of 3.1 years of follow-up, 97 (14.8%) patients died. The Kaplan-Meier analysis indicated that the long-term cumulative mortality was higher in patients with NT-pro-BNP >210 pg/mL compared with patients with NT-pro-BNP ≤210 pg/mL (log-rank=26.92, p<0.001). In multivariable Cox survival modelling, NT-pro-BNP >210 pg/mL was independently associated with long-term death (adjusted HR 2.47, 95% CI 1.45 to 4.22, p=0.001). CONCLUSIONS: NT-pro-BNP resulted as an independent predictor of adverse prognosis in patients with TBAD, thus could be used as a potential risk-stratification tool. BMJ Publishing Group 2019-09-05 /pmc/articles/PMC6731865/ /pubmed/31492783 http://dx.doi.org/10.1136/bmjopen-2019-029885 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Cardiovascular Medicine Luo, Changjun Zhou, Jianwei Xiong, Si Kang, Zhongqiang Zhang, Jing Sun, Yifan Qin, Biyun Fang, Kuaifa N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title | N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title_full | N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title_fullStr | N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title_full_unstemmed | N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title_short | N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study |
title_sort | n-terminal pro-b-type natriuretic peptide and outcomes in type b aortic dissection in china: a retrospective multicentre study |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731865/ https://www.ncbi.nlm.nih.gov/pubmed/31492783 http://dx.doi.org/10.1136/bmjopen-2019-029885 |
work_keys_str_mv | AT luochangjun nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT zhoujianwei nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT xiongsi nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT kangzhongqiang nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT zhangjing nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT sunyifan nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT qinbiyun nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy AT fangkuaifa nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy |